Peptidoglycan from Immunobiotic Lactobacillus rhamnosus Improves Resistance of Infant Mice to Respiratory Syncytial Viral Infection and Secondary Pneumococcal Pneumonia

Peptidoglycan from Immunobiotic Lactobacillus rhamnosus Improves Resistance of Infant Mice to Respiratory Syncytial Viral Infection and Secondary Pneumococcal Pneumonia

Several research works have demonstrated that beneficial microbes with the capacity to modulate the mucosal immune system (immunobiotics) are an interesting alternative to improve the outcome of bacterial and viral respiratory infections. Among the immunobiotic strains with the capacity to beneficia...

Full description

Bibliographic Details
Main Authors: Patricia Clua, Paulraj Kanmani, Hortensia Zelaya, Asuka Tada, A. K. M. Humayun Kober, Susana Salva, Susana Alvarez, Haruki Kitazawa, Julio Villena
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Immunology
Subjects:
immunobiotics
peptidoglycan
toll-like receptor 3
viral immunity
Streptococcus pneumoniae
respiratory syncytial virus
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.00948/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2017.00948/full

Similar Items